Why the study?
Does pharmacological activation with 1-EBIO, CZ, and ZOX increase the activity of cloned hIK1 and rSK2 channels in Xenopus oocytes?
Population
Xenopus oocytes heterologously expressing cloned intermediate-conductance and small-conductance…
Comparison
Pharmacological activation with… vs Absence of pharmacological activators
Design
Preclinical
Authors
Loading...
Activators of hIK1/rSK2 identified in oocytes; hypothesis-generating for vascular disease and cystic fibrosis therapies.
Does pharmacological activation with 1-EBIO, CZ, and ZOX increase the activity of cloned hIK1 and rSK2 channels in Xenopus oocytes?
1-EBIO, CZ, and ZOX are identified as the first known pharmacological activators of hIK1 and rSK2 channels, suggesting potential therapeutic utility for IK and SK channel openers in vascular diseases and cystic fibrosis.
Syme et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: